PrimeRFP SCOUT · Federal Contract Recompete Brief

HT940625FGPC17Cardiology products — Boston Scientific Corp

Boston Scientific Corp holds $69.8M across 5,464 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards under parent HT940623A0002. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 30, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

Boston Scientific Corp

Recipient

Sep 30, 2025

PoP end

$200K

Obligated

$200K

Potential

339112

NAICS

6515

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Boston Scientific Corp — $90

Contract facts

NONE

Contract numberHT940625FGPC17

Also listed asHT940623A0002-HT940625FGPC17

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentBoston Scientific Corp

CAGE1FKE6

UEIYWDHHW3DLNQ1

NAICS339112

No full NAICS 339112 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVHT940623A0002

Place of performanceMARLBOROUGH MA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startSep 30, 2025

PoP end (current)Sep 30, 2025

Obligated$200K

Current value$200K

Potential value$200K

CARDIOLOGY PRODUCTS is a federal NONE award for Defense Health Agency held by Boston Scientific Corp. Estimated value $200K ($200K obligated). Current period of performance ends Sep 30, 2025. Last award drew 1 bidder. Place of performance: MARLBOROUGH MA.

Recompete timing

Public

● Past PoP end (325 days ago)

Current PoP ended Sep 30, 2025 (325 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Boston Scientific Corp — $69.8M obligated across 5,464 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($69.8M) · all agencies

Department of Defense (DOD)$40.6M · 58%Department of Veterans Affairs (VA)$29.3M · 42%

Related awards

Same parent · incumbent

36C26126N0005

VAPAHCS THERASPHERE Y90 RADIOPHARMACEUTICALS

$954K

Sep 30, 2026

36C26126F0019

THERASPHERE YTTIRUM-90 (Y-90) GLASS

$834K

Sep 30, 2026

36C26226N0239

THERASPHERE Y-90

$693K

Sep 30, 2026

W81K0025PA252

TRANSARTERIAL RADIOEMBOLIZATION USING YTTRIUM-90 MICROSPHERES IS A THERAPEUTIC OPTION FOR …

$553K

Sep 30, 2026

36C26226N0070

THERASPHERE Y-90

$397K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT940625FGPC17?

HT940625FGPC17 (Cardiology products) is a Defense Health Agency award with a potential value of $200K, currently held by Boston Scientific Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HT940625FGPC17?

Defense Health Agency awarded HT940625FGPC17 to Boston Scientific Corp (potential $200K).

Who is the incumbent on HT940625FGPC17?

Boston Scientific Corp is the incumbent with $69.8M across 5464 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2025.

When does Boston Scientific Corp’s HT940625FGPC17 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Sep 24, 2025